Tracking a targeted cancer drug in everyday patients
NCT ID NCT04945330
Summary
This study is collecting information on how well the cancer drug larotrectinib works and what side effects patients experience when it's used in real-world medical care. It will follow about 100 adults and children whose cancer has an NTRK gene fusion and has spread or returned. Researchers will gather data from medical records and doctor visits over several years to understand the drug's real-life safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR RECURRENT SOLID TUMOR HARBORING AN NTRK GENE FUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
RECRUITINGMultiple Locations, Japan
Conditions
Explore the condition pages connected to this study.